JAZZ Jazz Pharmaceuticals, Inc.

XNAS 235.67 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

JAZZ $235.67 —
Key stats
$235.67
52-Week Range
$128.80 – $266.38
YTD
+36.11%
IV Rank (30D)
25.79
Straddle Price
$9.25
P/C Vol Ratio
0.20
Market Cap
$15.3B
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.26%
Beta vs SPY0.70
Cost of Equity (CAPM)8.76% (VRP-adj)
WACC8.04%
Volatility Risk Premium+39.7pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+7.3%
DCF Horizon12 years explicit + fade
Forward Tilt (NTM/TTM)×1.07 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$1.5B
Return on Equity (TTM)19.6%
Book / Price31.9% — banking bias active (P/B is primary)
Gross Margin (TTM)88.4%
FCF Margin (TTM)32.9%
Debt / Equity0.69
Quality Score4/6 — high quality (12y DCF)
Market-Implied Growth-5.2% (reverse-DCF on current price)
SMA 50$247.60 (Market Anchor value)
SMA 20 / Bollinger Mid$240.16
Bollinger Width / SMA203.2% (drives anchor stability)
Net Debt$1.7B
Market Cap$15B
Peers used for multiples: ABT, PFE, REGN (SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
72%
20-Day Fair Value
≈ by Nov 2, 2026
$238.76
α +1.3% rank 49%
conviction
79%
40-Day Fair Value
≈ by Dec 1, 2026
$242.79
α +3.0% rank 52%
conviction
83%
60-Day Fair Value
≈ by Dec 30, 2026
$241.52
α +2.5% rank 55%
conviction
72%
MethodImplied PriceWeightDetail
DCF $570.62 19%
DDM (Gordon) n/a 0%
Peer P/E $494.80 9% median 31.5× · 3 peers
Peer EV/EBITDA $454.72 9% median 18.0× · 3 peers
Peer P/B $183.07 2% median 2.5× · 3 peers
Peer P/S $280.82 6% median 3.7× · 3 peers
Market Anchor (SMA50) $247.60 38% stability 100% (BB-width)
Options Expected (B-L 30d) $232.51 19% 27 strikes · skew -0.90
As of 2026-10-02 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$15.3B

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +1.02% 19
Feb +0.37% 19
Mar +1.04% 19
Apr -0.97% 19
May +1.74% 19
Jun +16.34% 20
Jul +5.22% 20
Aug +0.76% 20
Sep -2.04% 20
Oct -2.52% 20
Nov +6.18% 19
Dec +4.22% 19
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $239.57
SMA 50: $247.21
SMA 200: $211.91
Current: $235.67
EMA 12: $236.87
EMA 26: $240.47
MACD: -3.6011 | Signal: -0.4765
BEARISH
ADX (14): 22.42
WEAK TREND
+DI: 15.44
−DI: 26.17

Momentum Oscillators

RSI (14): 42.85
NEUTRAL
Stoch %K: 22.71
Stoch %D: 20.61
Williams %R: -64.11

Volume & Volatility

BB Upper: $248.39
BB Lower: $230.74
NEUTRAL
OBV: 45,851,256
Vol SMA 20: 731,496
Vol ROC: -71.18%
ATR: $6.03
True Range: $6.07
HV 20: 21.2%
HV 30: 27.3%
HV 60: 27.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-04T00:00:00 – 2026-10-02T00:00:00
AI Analysis

LLM Stock Analysis Report: JAZZ

Executive Summary

Overall Assessment: NEUTRAL (6/10) - The stock is in a range-bound phase, with no clear trend direction or strong momentum signals. Key drivers include the recent acquisition of Actio and the potential catalysts from upcoming earnings and product launches.

Key Risks:

  1. Beta: 0.53 - low volatility relative to market
  2. Trend Indicators: Range-bound regime, with SMA 20 and EMA 12 indicating a neutral trend

Recent News Sentiment Impact: Positive (60%) - Headlines have been generally upbeat, driven by the acquisition of Actio and updates on product development.

Technical Analysis

Trend Direction: Neutral (Range-bound)

Support/Resistance Levels:

  • Upper Resistance: $257.11 (Bollinger Band Upper)
  • Middle Resistance: $246.54 (SMA 20)
  • Lower Support: $235.97 (Bollinger Band Lower)

Momentum Signals:

  • RSI (14): 43.64 (Neutral) - not overbought or oversold
  • MACD: Bearish signal line crossover (-2.03 / -0.41 / -1.62)
  • Bollinger Bands: Neutral signal, with price touching the middle band

Volume Analysis:

  • Volume SMA 20: 1103860.10 (Neutral) - not overly bullish or bearish
  • On-Balance Volume (OBV): 46942412.40 (Upward trending)
  • Volume Rate of Change: 336.29% (Bullish)

News & Sentiment Analysis

Recent Headlines Summary:

  1. Positive news from acquisition and product updates (60%)
  2. Neutral comments on market trends and analyst opinions (20%)
  3. Negative sentiment from earnings misses and regulatory issues (10%)

Sentiment Assessment: 55% Positive (Moderate sentiment)

Catalyst Identification:

  • Earnings Date: Upcoming earnings release potentially catalyzing the stock
  • Product Launches: Updates on product development and launches could drive price movements

Risk & Volatility Assessment

Risk Metrics:

  • Beta: 0.53 (Low) - stock moves less than market
  • Volatility Regime: Low volatility relative to historical levels

Options Market Signals:

  • IV Rank: 21.1% (Low) - shows if volatility is historically high/low
  • Current IV: 53.3%
  • Expected Move: $13.10 (28 DTE), 7-DTE: $2.52 - Options market pricing a potential move

Market Context & Positioning

Sector Performance:

  • JAZZ's sector is relatively strong, with a moderate upward trend

Institutional Activity:

  • Volume Patterns: Institutional interest seems moderate, with no clear trend direction

Correlation Analysis:

  • R-squared Interpretation: Correlated with market movements (0.19)

Relative Valuation:

  • Position within Trading Range: Neutral - not significantly overbought or oversold

Key Levels & Action Items

Critical Price Levels:

  • Support/Resistance: $257.11, $246.54, and $235.97 as mentioned above

Breakout/Breakdown Levels:

  • Uptrend Breakout: Above $257.11 (Upper Bollinger Band)
  • Downtrend Breakdown: Below $235.97 (Lower Bollinger Band)

Time-Sensitive Catalysts:

  • Earnings Date: Upcoming earnings release potentially catalyzing the stock

Risk Management:

  • Stop-loss Levels: Consider placing a stop-loss order around $234.50 (1.5% below Lower Bollinger Band)
  • Position Sizing: Be cautious with position sizing, considering the low volatility and moderate institutional interest
Generated
Earnings History
7 of 8 under expected move
Avg Expected Move
8.25%
Avg Actual Move
6.54%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-11-06 After-Close 6.89% 5.61% 0.81x Within
2025-01-13 After-Close 4.57% 0.16% 0.04x Within
2025-05-06 After-Close 8.66% 8.35% 0.96x Within
2025-08-05 After-Close 11.75% 6.42% 0.55x Within
2025-11-05 After-Close 9.14% 6.47% 0.71x Within
2026-02-24 After-Close 8.97% 13.59% 1.52x Exceeded
2026-05-05 After-Close 7.94% 7.69% 0.97x Within
2026-08-03 After-Close 8.05% 3.99% 0.50x Within

JAZZ Options Activity & IV Rank

JAZZ IV rank history, 52-week IV rank and IV percentile →

IV Rank (30D)
25.79
IV Rank (7D)
7.37
IV (30D ATM)
30.4%
Straddle (30D)
$9.25
Straddle (7D)
$9.25
P/C Volume
0.20
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.53
Correlation (SPY)
18.6%
R²
0.03
Ann. Volatility
37.0%
SPY Volatility
13.0%

Low volatility - stock moves less than market

Beta & Alpha Over Time

JAZZ Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 64,521,750 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

704 filers1,025,188,328 shares$18.20B value1588.90% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 112,559,603 $1.62B 8.90% 174.45% 2026-06-30
2 FMR LLC Custodian 16,414,326 $1.13B 6.21% 25.44% 2026-06-30
3 Vanguard Group Inc Custodian 5,917,142 $1.01B 5.53% 9.17% 2025-12-31
4 Vanguard Portfolio Management LLC 3,036,213 $731.64M 4.02% 4.71% 2026-06-30
5 Vanguard Capital Management LLC 2,729,650 $657.76M 3.61% 4.23% 2026-06-30
6 Capital World Investors 3,778,610 $651.89M 3.58% 5.86% 2026-06-30
7 LSV ASSET MANAGEMENT 2,275,145 $548.24M 3.01% 3.53% 2026-06-30
8 Franklin Resources, Inc. Custodian 27,040,250 $534.28M 2.94% 41.91% 2026-06-30
9 State Street Corp 27,551,816 $525.62M 2.89% 42.70% 2026-06-30
10 Dimensional Fund Advisors LP Custodian 1,713,592 $412.91M 2.27% 2.66% 2026-06-30
11 FULLER & THALER ASSET MANAGEMENT, INC. 1,638,544 $394.84M 2.17% 2.54% 2026-06-30
12 Citadel Advisors LLC Custodian 88,131,676 $391.31M 2.15% 136.59% 2026-06-30
13 Bank of New York Mellon Corp Custodian 1,878,013 $380.77M 2.09% 2.91% 2026-06-30
14 AQR Capital Management, LLC Custodian 1,522,568 $359.94M 1.98% 2.36% 2026-06-30
15 Geode Capital Management, LLC Custodian 1,483,031 $357.44M 1.96% 2.30% 2026-06-30
16 JPMorgan Chase & Co Custodian 19,216,786 $307.12M 1.69% 29.78% 2026-06-30
17 Ameriprise Financial, Inc. Custodian 9,215,523 $306.61M 1.68% 14.28% 2026-06-30
18 Bank of America Corp Custodian 1,136,091 $273.76M 1.50% 1.76% 2026-06-30
19 VOYA INVESTMENT MANAGEMENT LLC 145,855,432 $260.86M 1.43% 226.06% 2026-06-30
20 Swedbank AB 968,092 $233.28M 1.28% 1.50% 2026-06-30
21 Millennium Management LLC Custodian 23,763,880 $223.35M 1.23% 36.83% 2026-06-30
22 BNP PARIBAS ASSET MANAGEMENT Holding S.A. 8,699,297 $206.06M 1.13% 13.48% 2026-06-30
23 UBS Group AG Custodian 756,865 $182.38M 1.00% 1.17% 2026-06-30
24 Morgan Stanley Custodian 9,322,680 $166.55M 0.92% 14.45% 2026-06-30
25 Victory Capital Management Inc. 686,719 $165.48M 0.91% 1.06% 2026-06-30
11 filers$47.93M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $18.92M 39.47% 2026-06-30
2 Citadel Advisors LLC Custodian $11.25M 23.48% 2026-06-30
3 Caption Management, LLC $7.11M 14.83% 2026-06-30
4 Squarepoint Ops LLC $3.74M 7.79% 2026-06-30
5 Lombard Odier Asset Management (Europe) Ltd $3.23M 6.74% 2026-06-30
6 Jane Street Group, LLC Custodian $1.83M 3.82% 2026-06-30
7 Wolverine Trading, LLC Custodian $864.43K 1.80% 2025-09-30
8 IMC-Chicago, LLC Custodian $433.75K 0.91% 2026-06-30
9 Simplex Trading, LLC Custodian $289.16K 0.60% 2026-06-30
10 Point72 Asset Management, L.P. $192.78K 0.40% 2026-06-30
11 GROUP ONE TRADING LLC Custodian $72.29K 0.15% 2026-06-30
11 filers$51.34M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $22.87M 44.54% 2026-06-30
2 Portman Square Capital LLP $10.10M 19.66% 2026-06-30
3 Citadel Advisors LLC Custodian $7.78M 15.16% 2026-06-30
4 Squarepoint Ops LLC $2.72M 5.30% 2026-06-30
5 Jane Street Group, LLC Custodian $2.41M 4.69% 2026-06-30
6 Point72 Asset Management, L.P. $1.76M 3.43% 2026-06-30
7 WOLVERINE ASSET MANAGEMENT LLC $1.13M 2.21% 2026-06-30
8 GROUP ONE TRADING LLC Custodian $843.39K 1.64% 2026-06-30
9 DLD Asset Management, LP $723.09K 1.41% 2026-06-30
10 Wolverine Trading, LLC Custodian $619.30K 1.21% 2025-09-30
11 Simplex Trading, LLC Custodian $385.55K 0.75% 2026-06-30

JAZZ Insider Trading (Form 4)

Latest: 2026-09-14
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-14 Neena M Patil EVP & Chief Legal Officer Sell (S) −1,200 $240.94 -$289.1K EDGAR
2026-09-10 Renee D Gala President & CEO Mixed −3,967 $244.90 -$971.5K EDGAR
2026-09-10 Mary Elizabeth Henderson SVP, Technical Operations Tax (F) −1,427 $243.01 -$346.8K EDGAR
2026-09-02 Bruce C Cozadd Director Mixed −7,219 $248.66 -$1.80M EDGAR
2026-09-02 Patrick G Enright Director Tax (F) −1,706 $241.42 -$411.9K EDGAR
2026-09-02 Laura Hamill Director Tax (F) −1,706 $241.41 -$411.8K EDGAR
2026-09-02 Norbert G Riedel Director Tax (F) −1,706 $241.42 -$411.9K EDGAR
2026-09-02 Mary Elizabeth Henderson SVP, Technical Operations Tax (F) −2,092 $241.41 -$505.0K EDGAR
2026-09-02 Heather Ann McSharry Director Tax (F) −1,855 $241.42 -$447.8K EDGAR
2026-09-02 Ted W Love Director Tax (F) −743 $241.41 -$179.4K EDGAR
2026-09-02 Patrick Kennedy Director Tax (F) −1,855 $241.41 -$447.8K EDGAR
2026-09-02 Jennifer E. Cook Director Tax (F) −1,706 $241.41 -$411.8K EDGAR
2026-09-02 Mark Douglas Smith Director Tax (F) −1,706 $241.42 -$411.9K EDGAR
2026-09-02 Rick E Winningham Director Tax (F) −1,706 $241.42 -$411.9K EDGAR
2026-08-31 Robert Iannone EVP, Global Head of R&D & CMO Mixed −19,421 $196.72 -$11.97M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

JAZZ Insider Holdings

20 insiders · @ $235.67
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Seamus Mulligan Director 1,286,254 $303.13M -$270.18M 35 2026-08-07
2 Bruce C Cozadd Director 351,875 $82.93M -$93.91M 169 2026-09-02
3 Renee D Gala President & CEO 143,394 $33.79M -$1.70M 26 2026-09-10
4 Robert Iannone EVP, Global Head of R&D & CMO 111,223 $26.21M -$22.01M 24 2026-08-31
5 Philip L Johnson EVP & Chief Financial Officer 56,431 $13.30M $1.44M 6 2026-07-02
6 Neena M Patil EVP & Chief Legal Officer 47,671 $11.23M -$14.28M 31 2026-09-14
7 Samantha Pearce EVP, Chief Commercial Officer 47,131 $11.11M -$4.92M 29 2026-08-07
8 Kenneth W O'Keefe Director 30,256 $7.13M -$87.37M 38 2025-12-04
9 Mary Elizabeth Henderson SVP, Technical Operations 23,830 $5.62M -$1.57M 12 2026-09-10
10 Patrick G Enright Director 21,278 $5.01M -$228.70M 67 2026-09-02
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

JAZZ Proposed Insider Sales (Form 144)

Latest: 2026-10-01
Last 30d: 4 filings · $2.8M notice value  ·  Last 90d: 19 filings · $34.7M notice value · 15 unique filers · 32% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: ROBERT IANNONE (1, $19.2M) · Bruce C Cozadd (4, $5.0M) · Henderson Mary Elizabeth (2, $1.6M) · ORiordan Anne (1, $882K) · Kennedy Patrick (1, $858K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-10-01 Bruce C Cozadd Officer 6,000 $1.38M 2026-10-01 Merrill Lynch 10b5-1 EDGAR
2026-09-10 NEENA PATIL Officer 1,200 $289.1K 2026-09-10 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-09-08 Henderson Mary Elizabeth Director 2,691 $664.2K 2026-09-08 ETRADE FINANCIAL CORPORATION — EDGAR
2026-09-08 RENEE D GALA Officer 2,000 $486.1K 2026-09-08 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-09-01 Bruce C Cozadd Officer 6,000 $1.50M 2026-09-01 Merrill Lynch 10b5-1 EDGAR
2026-08-31 Kennedy Patrick Director 3,507 $857.6K 2026-08-31 ETRADE FINANCIAL CORPORATION — EDGAR
2026-08-31 Henderson Mary Elizabeth Director 3,852 $942.0K 2026-08-31 ETRADE FINANCIAL CORPORATION — EDGAR
2026-08-31 Smith Mark Douglas Director 3,507 $857.6K 2026-08-31 ETRADE FINANCIAL CORPORATION — EDGAR
2026-08-31 Cook Jennifer E. Director 3,507 $857.6K 2026-08-31 ETRADE FINANCIAL CORPORATION — EDGAR
2026-08-31 Hamill Laura Director 3,507 $857.6K 2026-08-31 ETRADE FINANCIAL CORPORATION — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
Recent SEC Filings
Latest: 2026-05-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-29 0001628280-26-039147 EDGAR
2026-05-05 0001232524-26-000024 EDGAR
2026-02-24 0001232524-26-000012 EDGAR
2026-01-12 0001193125-26-009899 EDGAR
2025-11-17 0001193125-25-283887 EDGAR
2025-11-05 0001232524-25-000073 EDGAR
2025-10-28 0001628280-25-046763 EDGAR
2025-10-22 0001193125-25-245815 EDGAR
2025-08-05 0001232524-25-000061 EDGAR
2025-07-25 0001232524-25-000051 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-24 0001232524-26-000013 EDGAR
2025-02-26 0001232524-25-000011 EDGAR
2024-02-28 0001232524-24-000015 EDGAR
2023-03-01 0001232524-23-000015 EDGAR
2022-03-01 0001232524-22-000012 EDGAR
2021-02-23 0001232524-21-000016 EDGAR
2020-02-25 0001232524-20-000016 EDGAR
2019-02-26 0001232524-19-000013 EDGAR
2018-02-27 0001232524-18-000018 EDGAR
2017-02-28 0001232524-17-000024 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-05 0001232524-26-000025 EDGAR
2025-11-05 0001232524-25-000074 EDGAR
2025-08-06 0001232524-25-000063 EDGAR
2025-05-07 0001232524-25-000027 EDGAR
2024-11-07 0001232524-24-000086 EDGAR
2024-08-01 0001232524-24-000068 EDGAR
2024-05-02 0001232524-24-000033 EDGAR
2023-11-08 0001232524-23-000052 EDGAR
2023-08-09 0001232524-23-000037 EDGAR
2023-05-10 0001232524-23-000026 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio16.1
P/B Ratio3.1
P/S Ratio3.3
EV/EBITDA11.1
TTM Revenue$4.6B
TTM Net Income$0.9B
TTM EPS$14.63
ROE19.6%
Debt/Equity0.91